United States· US:66096-191_d44ad1d9-cfb0-62c1-e053-2a95a90a323e
Ohm Cholesterol Aid
A medicinal product containing cholesterol; bos taurus bile; malmea depressa bark, registered in United States by OHM PHARMA INC..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- CHOLESTEROL; BOS TAURUS BILE; MALMEA DEPRESSA BARK
- Manufacturer
- OHM PHARMA INC.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1166096-191-05
- ndc11660961910559 mL in 1 BOTTLE, SPRAY (66096-191-05)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5a03d8e5-ccd1-4e7d-9b4e-8f9426f85dc6 GET /v1/drugs/5a03d8e5-ccd1-4e7d-9b4e-8f9426f85dc6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "13; 3; 5",
"substance": "CHOLESTEROL; BOS TAURUS BILE; MALMEA DEPRESSA BARK",
"productndc": "66096-191",
"dosage_form": "LIQUID",
"dea_schedule": null,
"strength_unit": "[hp_C]/59mL; [hp_X]/59mL; [hp_X]/59mL",
"application_number": null,
"marketing_category": "UNAPPROVED HOMEOPATHIC"
}See everything about cholesterol; bos taurus bile; malmea depressa bark.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.